PortfoliosLab logoPortfoliosLab logo
ISIN
US36256V8744
Issuer
GMO
Inception Date
Jul 2, 2019
Min. Investment
$750,000,000
Distribution Policy
Distributing
Asset Class
Equity
Asset Class Size
Small-Cap
Asset Class Style
Value

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

GCAVX Performance Chart

GMO U.S. Small Cap Value Fund (GCAVX) is up 18.5% since the beginning of the year. GCAVX is currently trading at $28 per share. Investors who bought $1,000 worth of GCAVX shares 5 years ago would now be looking at an investment worth $1,753.


Loading charts...

S&P 500 Index

Returns By Period

GMO U.S. Small Cap Value Fund (GCAVX) has returned 18.50% so far this year and 44.27% over the past 12 months.


GMO U.S. Small Cap Value Fund

1D
1.47%
1M
2.67%
YTD
18.50%
6M
15.82%
1Y
44.27%
3Y*
20.45%
5Y*
11.88%
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GCAVX Monthly Returns History

Based on dividend-adjusted daily data since Jul 5, 2019, GCAVX's average daily return is +0.06%, while the average monthly return is +1.27%. At this rate, an investment would double in approximately 4.6 years.

Historically, 58% of months were positive and 42% were negative. The best month was Nov 2020 with a return of +16.9%, while the worst month was Mar 2020 at -26.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, GCAVX closed higher 51% of trading days. The best single day was Mar 24, 2020 with a return of +10.1%, while the worst single day was Mar 16, 2020 at -13.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.57%1.01%-3.37%10.64%0.34%3.59%18.50%
20253.26%-4.87%-5.81%-4.56%7.38%3.29%1.16%8.97%2.49%-0.35%3.05%1.44%15.27%
2024-2.94%3.19%5.03%-6.18%5.95%-2.56%11.95%-1.52%-0.37%-1.64%9.44%-7.72%11.16%
202310.61%-1.83%-4.19%-3.03%-2.57%10.79%5.91%-3.68%-3.08%-5.41%7.96%11.62%22.72%
2022-4.33%0.41%-1.77%-5.47%3.22%-11.21%10.49%-4.21%-11.42%12.96%5.06%-5.70%-14.22%
20213.41%11.36%7.60%1.79%3.54%-1.91%-2.39%2.00%-1.66%3.25%-0.57%5.34%35.66%

Benchmark Metrics

GMO U.S. Small Cap Value Fund has an annualized alpha of 0.10%, beta of 1.05, and R2 of 0.62 versus S&P 500 Index. Calculated based on daily prices since July 05, 2019.

  • This fund participated in 113.62% of S&P 500 Index downside but only 110.08% of its upside - more exposed to losses than it benefited from rallies.
  • With beta of 1.05 and R2 of 0.62, this fund moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.

Alpha
0.10%
Beta
1.05
0.62
Upside Capture
110.08%
Downside Capture
113.62%

Expense Ratio

GCAVX has an expense ratio of 0.42%, placing it in the medium range.


Return for Risk

Risk / Return Rank

GCAVX ranks 77 for risk / return — better than 77% of mutual funds on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


GCAVX Risk / Return Rank: 7777
Overall Rank
GCAVX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
GCAVX Sortino Ratio Rank: 7575
Sortino Ratio Rank
GCAVX Omega Ratio Rank: 6161
Omega Ratio Rank
GCAVX Calmar Ratio Rank: 8989
Calmar Ratio Rank
GCAVX Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for GMO U.S. Small Cap Value Fund (GCAVX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GCAVXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+0.32

Sortino ratioReturn per unit of downside risk

+0.56

Omega ratioGain probability vs. loss probability

1.39

1.37

+0.03

Calmar ratioReturn relative to maximum drawdown

4.17

2.78

+1.38

Martin ratioReturn relative to average drawdown

14.60

12.44

+2.16

Dividends

Dividend History

GMO U.S. Small Cap Value Fund provided a 2.48% dividend yield over the last twelve months, with an annual payout of $0.69 per share.


0.00%10.00%20.00%30.00%40.00%$0.00$2.00$4.00$6.00$8.002019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022202120202019
Dividend$0.69$0.69$0.35$0.35$1.73$8.46$0.33$0.18

Dividend yield

2.48%2.94%1.68%1.85%10.92%41.19%1.54%0.83%

Monthly Dividends

The table displays the monthly dividend distributions for GMO U.S. Small Cap Value Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.05$0.00$0.00$0.00$0.00$0.64$0.69
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.35$0.35
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.06$0.00$0.00$0.00$0.00$0.30$0.35
2022$0.00$0.00$0.00$0.00$0.00$0.00$1.32$0.00$0.00$0.00$0.00$0.41$1.73
2021$0.00$0.00$0.00$0.00$0.00$0.00$1.70$0.00$0.00$0.00$0.00$6.77$8.46

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the GMO U.S. Small Cap Value Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GMO U.S. Small Cap Value Fund was 48.22%, occurring on Mar 18, 2020. Recovery took 182 trading sessions.

The current GMO U.S. Small Cap Value Fund drawdown is 1.32%.


Related event

Drawdown

Fall

Recovery

Underwater

COVID crash2020
-48.22%Mar 2020
2mo 1d8mo 21d
10mo 22dJan 2020 - Dec 2020
2025 selloff2025
-26.15%Apr 2025
4mo 13d5mo
9mo 13dNov 2024 - Sep 2025
Bear market2022
-25.66%Sep 2022
10mo 15d1y 2mo
2y 29dNov 2021 - Dec 2023
2021 correction2021
-11.93%Jul 2021
1mo 10d3mo 17d
4mo 27dJun 2021 - Nov 2021
2026 correction2026
-10.64%Mar 2026
1mo 6d28d
2mo 4dFeb 2026 - Apr 2026

Drawdown Indicators


GCAVXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-48.22%

-56.78%

+8.56%

Max Drawdown (1Y)

Largest decline over 1 year

-10.64%

-9.10%

-1.54%

Max Drawdown (3Y)

Largest decline over 3 years

-26.15%

-18.90%

-7.25%

Max Drawdown (5Y)

Largest decline over 5 years

-26.15%

-25.43%

-0.72%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-1.32%

-1.80%

+0.48%

Average Drawdown

Average peak-to-trough decline

-8.50%

-10.71%

+2.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.03%

2.03%

+1.00%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with GCAVX

Add GMO U.S. Small Cap Value Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with GCAVX